Viewing Study NCT00258232


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-01-01 @ 11:57 PM
Study NCT ID: NCT00258232
Status: COMPLETED
Last Update Posted: 2013-04-08
First Post: 2005-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module